Plasma androgens after a single oral dose of testosterone undecanoate
- PMID: 7387164
- PMCID: PMC1626771
- DOI: 10.1136/adc.55.3.218
Plasma androgens after a single oral dose of testosterone undecanoate
Abstract
Total plasma androgens (PA) were measured in 9 hypogonadal males aged between 13 and 21 1/2 years after a single oral dose of testosterone undecanoate (TU). With the exception of one patient, all showed a rise in PA with peak values between 7.7 and 38.0 nmol/l at 2 to 7 hours. A further patient aged 15.7 years who was given an 80-mg dose had a peak PA level of 71.2 nmol/l. In all patients PA returned to basal levels at 24 hours. In 4 patients plasma testosterone and dihydrotestosterone were measured, both rose after oral TU, and relatively high plasma dihydrotestosterone values were obtained. While these results indicate that TU is effective in young people, the very high peak androgen levels found in several of them after 40 mg TU suggest that this dose may be excessive in patients in whom growth is not complete.
Similar articles
-
Testosterone undecanoate: a new orally active androgen.Acta Endocrinol (Copenh). 1975 Sep;80(1):179-87. doi: 10.1530/acta.0.0800179. Acta Endocrinol (Copenh). 1975. PMID: 1098350 Clinical Trial.
-
Influence of various modes of androgen substitution on serum lipids and lipoproteins in hypogonadal men.Metabolism. 1999 May;48(5):590-6. doi: 10.1016/s0026-0495(99)90056-2. Metabolism. 1999. PMID: 10337859 Clinical Trial.
-
Reexamination of pharmacokinetics of oral testosterone undecanoate in hypogonadal men with a new self-emulsifying formulation.J Androl. 2012 Mar-Apr;33(2):190-201. doi: 10.2164/jandrol.111.013169. Epub 2011 Apr 7. J Androl. 2012. PMID: 21474786 Free PMC article. Clinical Trial.
-
Emerging medication for the treatment of male hypogonadism.Expert Opin Emerg Drugs. 2016 Sep;21(3):255-66. doi: 10.1080/14728214.2016.1226799. Expert Opin Emerg Drugs. 2016. PMID: 27552127 Review.
-
Testosterone undecanoate in the treatment of male hypogonadism.Expert Opin Pharmacother. 2010 Aug;11(12):2095-106. doi: 10.1517/14656566.2010.505920. Expert Opin Pharmacother. 2010. PMID: 20642374 Review.
Cited by
-
Pharmacokinetics of sex steroids in patients with beta thalassaemia major.J Clin Pathol. 1993 Jul;46(7):660-4. doi: 10.1136/jcp.46.7.660. J Clin Pathol. 1993. PMID: 8157756 Free PMC article.
-
Testosterone disrupts human collaboration by increasing egocentric choices.Proc Biol Sci. 2012 Jun 7;279(1736):2275-80. doi: 10.1098/rspb.2011.2523. Epub 2012 Feb 1. Proc Biol Sci. 2012. PMID: 22298852 Free PMC article. Clinical Trial.
-
Absolute bioavailability of testosterone after oral administration of testosterone-undecanoate and testosterone.Eur J Drug Metab Pharmacokinet. 1987 Jul-Sep;12(3):225-6. doi: 10.1007/BF03189902. Eur J Drug Metab Pharmacokinet. 1987. PMID: 3436346 No abstract available.
-
A double blind, placebo controlled study of the effects of low dose testosterone undecanoate on the growth of small for age, prepubertal boys.Arch Dis Child. 1995 Aug;73(2):131-5. doi: 10.1136/adc.73.2.131. Arch Dis Child. 1995. PMID: 7574856 Free PMC article. Clinical Trial.
-
Treatment of the short, sexually immature adolescent boy.Arch Dis Child. 1994 Oct;71(4):285-7. doi: 10.1136/adc.71.4.285. Arch Dis Child. 1994. PMID: 7979517 Free PMC article. Review. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources